Milas L - Search Results

1

Flavopiridol increases therapeutic ratio of radiotherapy by preferentially enhancing tumor radioresponse.

Mason KA, Hunter NR, Raju U, Ariga H, Husain A, Valdecanas D, Neal R, Ang KK, Milas L. Mason KA, et al. Among authors: milas l. Int J Radiat Oncol Biol Phys. 2004 Jul 15;59(4):1181-9. doi: 10.1016/j.ijrobp.2004.03.003. Int J Radiat Oncol Biol Phys. 2004. PMID: 15234054

2

Relationship between cyclin D1 expression and poor radioresponse of murine carcinomas.

Milas L, Akimoto T, Hunter NR, Mason KA, Buchmiller L, Yamakawa M, Muramatsu H, Ang KK. Milas L, et al. Int J Radiat Oncol Biol Phys. 2002 Feb 1;52(2):514-21. doi: 10.1016/s0360-3016(01)02693-1. Int J Radiat Oncol Biol Phys. 2002. PMID: 11872299

3

In vitro enhancement of tumor cell radiosensitivity by a selective inhibitor of cyclooxygenase-2 enzyme: mechanistic considerations.

Raju U, Nakata E, Yang P, Newman RA, Ang KK, Milas L. Raju U, et al. Among authors: milas l. Int J Radiat Oncol Biol Phys. 2002 Nov 1;54(3):886-94. doi: 10.1016/s0360-3016(02)03023-7. Int J Radiat Oncol Biol Phys. 2002. PMID: 12377342

4

Poly(L-glutamic acid)-paclitaxel conjugate is a potent enhancer of tumor radiocurability.

Milas L, Mason KA, Hunter N, Li C, Wallace S. Milas L, et al. Int J Radiat Oncol Biol Phys. 2003 Mar 1;55(3):707-12. doi: 10.1016/s0360-3016(02)04153-6. Int J Radiat Oncol Biol Phys. 2003. PMID: 12573758

5

Flavopiridol, a cyclin-dependent kinase inhibitor, enhances radiosensitivity of ovarian carcinoma cells.

Raju U, Nakata E, Mason KA, Ang KK, Milas L. Raju U, et al. Among authors: milas l. Cancer Res. 2003 Jun 15;63(12):3263-7. Cancer Res. 2003. PMID: 12810657

6

The epidermal growth factor receptor mediates radioresistance.

Liang K, Ang KK, Milas L, Hunter N, Fan Z. Liang K, et al. Among authors: milas l. Int J Radiat Oncol Biol Phys. 2003 Sep 1;57(1):246-54. doi: 10.1016/s0360-3016(03)00511-x. Int J Radiat Oncol Biol Phys. 2003. PMID: 12909240

7

Potentiation of tumor response to radiation or chemoradiation by selective cyclooxygenase-2 enzyme inhibitors.

Nakata E, Mason KA, Hunter N, Husain A, Raju U, Liao Z, Ang KK, Milas L. Nakata E, et al. Among authors: milas l. Int J Radiat Oncol Biol Phys. 2004 Feb 1;58(2):369-75. doi: 10.1016/j.ijrobp.2003.09.061. Int J Radiat Oncol Biol Phys. 2004. PMID: 14751505

8

Epidermal growth factor receptor and response of head-and-neck carcinoma to therapy.

Ang KK, Andratschke NH, Milas L. Ang KK, et al. Among authors: milas l. Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):959-65. doi: 10.1016/j.ijrobp.2003.07.010. Int J Radiat Oncol Biol Phys. 2004. PMID: 14967456 Review.

9

Epidermal growth factor receptor and tumor response to radiation: in vivo preclinical studies.

Milas L, Fan Z, Andratschke NH, Ang KK. Milas L, et al. Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):966-71. doi: 10.1016/j.ijrobp.2003.08.035. Int J Radiat Oncol Biol Phys. 2004. PMID: 14967457

10

C225 antiepidermal growth factor receptor antibody enhances the efficacy of docetaxel chemoradiotherapy.

Nakata E, Hunter N, Mason K, Fan Z, Ang KK, Milas L. Nakata E, et al. Among authors: milas l. Int J Radiat Oncol Biol Phys. 2004 Jul 15;59(4):1163-73. doi: 10.1016/j.ijrobp.2004.02.050. Int J Radiat Oncol Biol Phys. 2004. PMID: 15234052

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

316 results

Search Page

Filters